Cardiac Rhythm Device Reading List

The following texts are listed by IBHRE as possible resources for exam preparation. The lists below are not exclusive as other texts may also prove useful for the purpose of exam preparation. By listing the texts below, IBHRE does not imply that all texts should be consulted in preparation for the exam. Familiarity with any or all of these texts does not guarantee successful completion of the exam.

Cardiac Rhythm Device Therapy Core Reading List for the Physician and Allied Professional

Updated 2017

1. Friedman PA, Rott MA, Wokhlu A, Asirvatham SJ, Hayes DL. A Case-Based Approach to Pacemakers, ICDs, and Cardiac Resynchronization: Introductory AND Advanced Questions for Examination Review and Clinical Practice (2 volume set). Minneapolis, MN: Cardiotext Publishing; 2013.
2. Ellenbogen KA, Kay GN, Wilkoff BL, Lau CP. Clinical Cardiac Pacing and Defibrillation. 4 ed. Philadelphia: W.B. Saunders, 2013.
3. Hayes DL, Friedman RA. Cardiac Pacing, Defibrillation and Resynchronization: A Clinical Approach. 3 ed. Hoboken NJ: Wiley-Blackwell, 2008.
4. Barold SS, Stroobandt RX, Sinnaeve AF, Cardiac Pacemakers Step by Step: An Illustrated Guide. Hoboken NJ: Wiley-Blackwell, 2003.
5. Ellenbogen, KA, and Wood,MA. Cardiac Pacing and ICDs, 6th ed. Hoboken NJ: Wiley Blackwell. 2014.
6. Strooband X, Barold S, Sinnaeve AF. Implantable Cardioverter-Defibrillators Step-by-Step: An Illustrated Guide. Hoboken NJ: Wiley-Blackwell, 2009.
7. Epstein A et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities, 2012. 
8. Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B, North American Society of Pacing and Electrophysiology (NASPE) Practice Guideline Committee. Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators: A Practical Guide to Patient Treatment. Archives of Internal Medicine. 161(5):649-55, 2001.
9. McAlister FA, Cardiac Resynchronization Therapy for Patients with Left Ventricular Systolic Dysfunction: A Systematic Review. JAMA. 2007; 297: 2502-2514.
10. Swerdlow C & Friedman P Advanced ICD Troubleshooting Part I PACE 2005; 28: 1322-1346.
11. Swerdlow C & Friedman P Advanced ICD Troubleshooting Part II PACE 2006;29(1):70-96.

Extended Reading List

1. Fogoros, RN. Antiarrhythmic Drugs: A Practical Guide. 2nd ed. Malden, MA: Blackwell Publishing, Inc. 2007.
2. Hayes DL, Asirvatham, SJ. Dictionary of Cardiac Pacing, Defibrillation, Resynchronization and Arrhythmias. Minneapolis, MN: Cardiotext Publishing, 2007.
3. Ellenbogen KA, Kay GN, Wilkoff BL, Lau CP. Clinical Cardiac Pacing and Defibrillation. 4 ed. Philadelphia: W.B. Saunders, 2011.
4. Hayes DL, Friedman RA. Cardiac Pacing, Defibrillation and Resynchronization: A Clinical Approach. Hoboken NJ: Wiley-Blackwell, 2008.
5. Barold SS, Ritter P. Devices for Cardiac Resynchronization:: Technologic and Clinical Aspects, New York, NY: Springer, 2007.
6. Barold SS, Stroobandt RX, Sinnaeve AF, Cardiac Pacemakers Step by Step: An Illustrated Guide. Hoboken NJ: Wiley-Blackwell, 2003.
7. Ellenbogen, KA, and Wood,MA. Cardiac Pacing and ICDs, 5th ed. Hoboken NJ: Wiley Blackwell. 2008.
8. Strooband X, Barold S, Sinnaeve AF. Implantable Cardioverter-Defibrillators Step-by-Step: An Illustrated Guide. Hoboken NJ: Wiley-Blackwell, 2009.
9. Yu CM, Hayes DL, Auricchio A. Cardiac Resynchronization Therapy. 2nd edition. Hoboken NJ: Wiley-Blackwell. 2008.

Defibrillation

1. A Comparison of Antiarrhythmic-Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Near-Fatal Ventricular Arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. New England Journal of Medicine 1997; 337(22): 1576-1583.
2. Bristow MR. Saxon LA. Boehmer J. Krueger S. Kass DA. De Marco T. Carson P. DiCarlo L. DeMets D. White BG. DeVries DW. Feldman AM. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-Resynchronization Therapy With or Without an Implantable Defibrillator in Advanced Chronic Heart Failure. New England Journal of Medicine. 350(21):2140-50, 2004.
3. Buxton AE, Lee KL, DiCarlo L, Echt DS, Fisher JD, Greer GS, Josephson ME, Packer D, Prystowsky EN, Talajic M. Nonsustained Ventricular Tachycardia in Coronary Artery Disease: Relation to Inducible Sustained Ventricular Tachycardia. MUSTT Investigators. Annals of Internal Medicine 1996; 125(1): 35-39.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A Randomized Study of the Prevention of Sudden Death in Patients With Coronary Artery Disease. New England Journal of Medicine 1999; 341(25): 1882-1890.
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A Randomized Study of the Prevention of Sudden Death in Patients With Coronary Artery Disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine 1999; 341(25): 1882-1890.
6. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. Electrophysiologic Testing to Identify Patients With Coronary Artery Disease Who Are at Risk for Sudden Death. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine 2000; 342(26): 1937-1945.
7. Causes of Death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. The AVID Investigators. Journal of the American College of Cardiology 1999; 34(5): 1552-1559.
8. Domanski MJ, Saksena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S. Relative Effectiveness of the Implantable Cardioverter-Defibrillator and Antiarrhythmic Drugs in Patients With Varying Degrees of Left Ventricular Dysfunction Who Have Survived Malignant Ventricular Arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. Journal of the American College of Cardiology 1999; 34(4): 1090-1095.
9. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy. New England Journal of Medicine. 350(21):2151-8, 2004. 
10. Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S, Brodsky M, Powell J. Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable. Circulation 2002; 105(17): 2049-2057.
11. Lee KL, Hafley G, Fisher JD, Gold MR, Prystowsky EN, Talajic M, Josephson ME, Packer DL, Buxton AE, Multicenter Unsustained Tachycardia Trial Investigators. Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial. Circulation 2002; 106(2): 233-238.
12. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, III, Spirito P. Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients With Hypertrophic Cardiomyopathy. New England Journal of Medicine 2000; 342(6): 365-373.
13. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine, JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved Survival With an Implanted Defibrillator in Patients With Coronary Disease at High Risk for Ventricular Arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New England Journal of Medicine 1996; 335(26):1933-1940.
14. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL. Prophylactic Implantation of a Defibrillator in Patients With Myocardial Infarction and Reduced Ejection Fraction. New England Journal of Medicine 2002; 346(12): 877-883.
15. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J. Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks. Circulation 2002; 105(5): 589-594.
16. Swerdlow C et al The Dilemma of ICD Implant Testing PACE 2007: 30: 675-700.
17. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO. PainFREE Investigators. Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease. Circulation. 104(7):796-801, 2001.

Pacing

1. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS). A Randomized Trial of Permanent Cardiac Pacing for the Prevention of Vasovagal Syncope. Journal of the American College of Cardiology 1999; 33(1): 16-20.
2. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of Physiologic Pacing Versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes. Canadian Trial of Physiologic Pacing Investigators. New England Journal of Medicine 2000; 342(19): 1385-1391.
3. Ellenbogen KA. Cardiac Pacing. Cardiology Clinics 18, 1-239. 2000.
4. Epstein A et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities, 2012.
5. Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B, North American Society of Pacing and Electrophysiology (NASPE) Practice Guideline Committee. Environmental and Drug Effects on Patients With Pacemakers and Implantable Cardioverter/Defibrillators: A Practical Guide to Patient Treatment. Archives of Internal Medicine. 161(5):649-55, 2001.
6. Josephson ME, Maloney JD, Barold SS, Flowers NC, Goldschlager NF, Hayes DL et al. Guidelines for Training in Adult Cardiovascular Medicine. Core Cardiology Training Symposium (COCATS 3). Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing and Arrhythmia Management. Journal of the American College of Cardiology 2008; 51:374-80.
7. Lamas GA. Ellenbogen KA. Evidence Base for Pacemaker Mode Selection: From Physiology to Randomized Trials. Circulation. 109(4):443-51, 2004.
8. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G. Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction. New England Journal of Medicine 2002; 346(24): 1854-1862.
9. Sutton R. Guidelines for Pacemaker Follow Up. Report of a British Pacing and Electrophysiology Group (BPEG). Heart 1996; 76(5): 458-460.

Biventricular Pacing

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M. Cardiac Resynchronization in Chronic Heart Failure. New England Journal of Medicine 2002; 346(24): 1845-1853.
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC, Multisite Stimulation iC. Effects of Multisite Biventricular Pacing in Patients With Heart Failure and Intraventricular Conduction Delay. New England Journal of Medicine 2001; 344(12): 873-880.
3. Cleland J et al The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF) New England Journal of Medicine 2005; 352:1539-1549.
4. Ellenbogen KA, Kay GN, Wilkoff BL (eds.), Device Therapy for Congestive Heart Failure Elsevier Science, Philadelphia, Pennsylvania, 2004.
5. Kuhlkamp V, The I., Initial Experience With an Implantable Cardioverter-Defibrillator Incorporating Cardiac Resynchronization Therapy. Journal of the American College of Cardiology 2002; 39(5): 790-797.
6. Lozano I, Bocchiardo M, Achtelik M, Gaita F, Trappe HJ, Daoud E, Hummel J, Duby C. Impact of Biventricular Pacing on Mortality in a Randomized Crossover Study of Patients With Heart Failure and Ventricular Arrhythmias. Pacing & Clinical Electrophysiology 2000; 23(11 Pt 2): 1711-1712.
7. McAllister FA Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction A Systematic Review JAMA 2007 297: 2502-2514.
8. Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E, VIGOR C. Effects of Long-Term Biventricular Stimulation for Resynchronization on Echocardiographic Measures of Remodeling. Circulation 2002; 105(11): 1304-1310.
9. Stellbrink C, Breithardt OA, Franke A, Sack S, Bakker P, Auricchio A, Pochet T, Salo R. Impact of Cardiac Resynchronization Therapy Using Hemodynamically Optimized Pacing on Left Ventricular Remodeling in Patients With Congestive Heart Failure and Ventricular Conduction Disturbances. Journal of the American College of Cardiology 2001; 38(7): 1957-1965.

Lead Extraction

1. Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Reiser C. Clinical Study of the Laser Sheath for Lead Extraction: The Total Experience in the United States. PACE 2002; 25(5): 804-808.
2. Henrikson CA, Brinker JA, How to prevent, recognize, and manage complications of lead extraction Part 1: Avoiding lead extraction—infectious issues, Heart Rhythm 2008; 5(7): 1083-1087.
3. Henrikson CA, Brinker JA, How to prevent, recognize, and manage complications of lead extraction. Part II: Avoiding lead extraction—noninfectious issues. Heart Rhythm 2008; 5(8): 1221-1223.
4. Henrikson CA, Brinker JA, How to prevent, recognize, and manage complications of lead extraction. Part III: Procedural factors. Heart Rhythm 2008; 5(9): 1352-1354.
5. Kay GN, Brinker JA, Kawanishi DT, Love CJ, Lloyd MA, Reeves RC, Pioger G, Overland MK, Ensign LG, Grunkemeier GL. The Risks of Spontaneous Injury and Extraction of an Active Fixation Pacemaker Lead: Report of the Accufix Multicenter Clinical Study and World-Wide Registry. Circulation 1999; 100: 2344-2352.
6. Wilkoff B, Love C et al Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management. Heart Rhythm 2009; 6 (7), 1085- 1104.

Papers & Guidelines

1. Epstein A et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities, 2012.
2. Maisel W, Hauser R et al, Recommendations from the HRS Task Force on Lead Performance Policies & Guidelines, Heart Rhythm  6(6), 2009.
3. McAlister FA, Cardiac Resynchronization Therapy for Patients with Left Ventricular Systolic Dysfunction: A Systematic Review. JAMA. 2007; 297: 2502-2514.
4. Swerdlow C & Friedman P Advanced ICD Troubleshooting Part I PACE 2005; 28: 1322-1346.
5. Swerdlow C & Friedman P Advanced ICD Troubleshooting Part II PACE 2006;29(1):70-96.
6. Wilkoff et al, HRS Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices, Heart Rhythm 2008;5(6), 907-925.